Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Leentjens, T. Haaps, P. Wessels, R. Schutgens, S. Middeldorp (2021)
COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 yearThe Lancet. Haematology, 8
(2020)
Endotheliopathy in COVID19-associated coagulopathy: evidence from a single-centre, cross-sectional study
( Leentjens J , van Haaps TF , Wessels PF , Schutgens REG , Middeldorp S . COVID‐19‐associated coagulopathy and antithrombotic agents—lessons after 1 year. Lancet Haematol. 2021;8(7):e524‐e533. doi:10.1016/s2352-3026(21)00105-8 33930350)
Leentjens J , van Haaps TF , Wessels PF , Schutgens REG , Middeldorp S . COVID‐19‐associated coagulopathy and antithrombotic agents—lessons after 1 year. Lancet Haematol. 2021;8(7):e524‐e533. doi:10.1016/s2352-3026(21)00105-8 33930350Leentjens J , van Haaps TF , Wessels PF , Schutgens REG , Middeldorp S . COVID‐19‐associated coagulopathy and antithrombotic agents—lessons after 1 year. Lancet Haematol. 2021;8(7):e524‐e533. doi:10.1016/s2352-3026(21)00105-8 33930350, Leentjens J , van Haaps TF , Wessels PF , Schutgens REG , Middeldorp S . COVID‐19‐associated coagulopathy and antithrombotic agents—lessons after 1 year. Lancet Haematol. 2021;8(7):e524‐e533. doi:10.1016/s2352-3026(21)00105-8 33930350
( Filbin MR , Mehta A , Schneider AM , et al. Longitudinal proteomic analysis of severe COVID‐19 reveals survival‐associated signatures, tissue‐specific cell death, and cell‐cell interactions. Cell Rep Med. 2021;2(5):100287. doi:10.1016/j.xcrm.2021.100287 33969320)
Filbin MR , Mehta A , Schneider AM , et al. Longitudinal proteomic analysis of severe COVID‐19 reveals survival‐associated signatures, tissue‐specific cell death, and cell‐cell interactions. Cell Rep Med. 2021;2(5):100287. doi:10.1016/j.xcrm.2021.100287 33969320Filbin MR , Mehta A , Schneider AM , et al. Longitudinal proteomic analysis of severe COVID‐19 reveals survival‐associated signatures, tissue‐specific cell death, and cell‐cell interactions. Cell Rep Med. 2021;2(5):100287. doi:10.1016/j.xcrm.2021.100287 33969320, Filbin MR , Mehta A , Schneider AM , et al. Longitudinal proteomic analysis of severe COVID‐19 reveals survival‐associated signatures, tissue‐specific cell death, and cell‐cell interactions. Cell Rep Med. 2021;2(5):100287. doi:10.1016/j.xcrm.2021.100287 33969320
( Bongiovanni D , Klug M , Lazareva O , et al. SARS‐CoV‐2 infection is associated with a pro‐thrombotic platelet phenotype. Cell Death Dis. 2021;12(1):50. doi:10.1038/s41419-020-03333-9.33414384)
Bongiovanni D , Klug M , Lazareva O , et al. SARS‐CoV‐2 infection is associated with a pro‐thrombotic platelet phenotype. Cell Death Dis. 2021;12(1):50. doi:10.1038/s41419-020-03333-9.33414384Bongiovanni D , Klug M , Lazareva O , et al. SARS‐CoV‐2 infection is associated with a pro‐thrombotic platelet phenotype. Cell Death Dis. 2021;12(1):50. doi:10.1038/s41419-020-03333-9.33414384, Bongiovanni D , Klug M , Lazareva O , et al. SARS‐CoV‐2 infection is associated with a pro‐thrombotic platelet phenotype. Cell Death Dis. 2021;12(1):50. doi:10.1038/s41419-020-03333-9.33414384
R. Martín-Rojas, G. Pérez‐Rus, Valeria Delgado-Pinos, A. Domingo-González, Isabel Regalado-Artamendi, Natalia Alba-Urdiales, P. Demelo-Rodríguez, S. Monsalvo, G. Rodríguez-Macías, M. Ballesteros, S. Osorio-Prendes, J. Díez-Martín, C. Pascual (2020)
COVID‐19 coagulopathy: An in‐depth analysis of the coagulation systemEuropean Journal of Haematology, 105
( Stefely JA , Christensen BB , Gogakos T , et al. Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism. Am J Hematol. 2020;95(12):1522‐1530. doi:10.1002/ajh.25979 32833259)
Stefely JA , Christensen BB , Gogakos T , et al. Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism. Am J Hematol. 2020;95(12):1522‐1530. doi:10.1002/ajh.25979 32833259Stefely JA , Christensen BB , Gogakos T , et al. Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism. Am J Hematol. 2020;95(12):1522‐1530. doi:10.1002/ajh.25979 32833259, Stefely JA , Christensen BB , Gogakos T , et al. Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism. Am J Hematol. 2020;95(12):1522‐1530. doi:10.1002/ajh.25979 32833259
M. Filbin, Arnav Mehta, Alexis Schneider, Kyle Kays, Jamey Guess, M. Gentili, Bank Fenyves, Nicole Charland, Anna Gonye, Irena Gushterova, Hargun Khanna, Thomas LaSalle, Kendall Lavin-Parsons, B. Lilley, Carl Lodenstein, Kasidet Manakongtreecheep, J. Margolin, Brenna Mckaig, Maricarmen Rojas-Lopez, Brian Russo, Nihaarika Sharma, Jessica Tantivit, Molly Thomas, R. Gerszten, Graham Heimberg, P. Hoover, David Lieb, B. Lin, D. Ngo, K. Pelka, Miguel Reyes, C. Smillie, Avinash Waghray, Thomas Wood, Amanda Zajac, L. Jennings, I. Grundberg, R. Bhattacharyya, B. Parry, A. Villani, Moshe Sade-Feldman, N. Hacohen, M. Goldberg (2021)
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactionsCell Reports Medicine, 2
D. Bongiovanni, M. Klug, O. Lazareva, S. Weidlich, M. Biasi, S. Ursu, Sarah Warth, C. Buske, M. Lukas, C. Spinner, M. Scheidt, G. Condorelli, J. Baumbach, K. Laugwitz, M. List, I. Bernlochner (2021)
SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotypeCell Death & Disease, 12
( Martín‐Rojas RM , Pérez‐Rus G , Delgado‐Pinos VE , et al. COVID‐19 coagulopathy: an in‐depth analysis of the coagulation system. Eur J Haematol. 2020;105(6):741‐750. doi:10.1111/ejh.13501 32749010)
Martín‐Rojas RM , Pérez‐Rus G , Delgado‐Pinos VE , et al. COVID‐19 coagulopathy: an in‐depth analysis of the coagulation system. Eur J Haematol. 2020;105(6):741‐750. doi:10.1111/ejh.13501 32749010Martín‐Rojas RM , Pérez‐Rus G , Delgado‐Pinos VE , et al. COVID‐19 coagulopathy: an in‐depth analysis of the coagulation system. Eur J Haematol. 2020;105(6):741‐750. doi:10.1111/ejh.13501 32749010, Martín‐Rojas RM , Pérez‐Rus G , Delgado‐Pinos VE , et al. COVID‐19 coagulopathy: an in‐depth analysis of the coagulation system. Eur J Haematol. 2020;105(6):741‐750. doi:10.1111/ejh.13501 32749010
Jonathan Stefely, Bianca Christensen, T. Gogakos, Jensyn Sullivan, Gabriella Montgomery, J. Barranco, E. Cott (2020)
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolismAmerican Journal of Hematology, 95
( Goshua G , Pine AB , Meizlish ML , et al. Endotheliopathy in COVID‐19‐associated coagulopathy: evidence from a single‐centre, cross‐sectional study. Lancet Haematol. 2020;7(8):e575‐e582. doi:10.1016/S2352-3026(20)30216-7 32619411)
Goshua G , Pine AB , Meizlish ML , et al. Endotheliopathy in COVID‐19‐associated coagulopathy: evidence from a single‐centre, cross‐sectional study. Lancet Haematol. 2020;7(8):e575‐e582. doi:10.1016/S2352-3026(20)30216-7 32619411Goshua G , Pine AB , Meizlish ML , et al. Endotheliopathy in COVID‐19‐associated coagulopathy: evidence from a single‐centre, cross‐sectional study. Lancet Haematol. 2020;7(8):e575‐e582. doi:10.1016/S2352-3026(20)30216-7 32619411, Goshua G , Pine AB , Meizlish ML , et al. Endotheliopathy in COVID‐19‐associated coagulopathy: evidence from a single‐centre, cross‐sectional study. Lancet Haematol. 2020;7(8):e575‐e582. doi:10.1016/S2352-3026(20)30216-7 32619411
American Journal of Hematology – Wiley
Published: Dec 1, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.